Kelly Huller insider trades: Globus Medical (GMED) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Kelly reports to the SEC
Open-market buys and sales
17 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | GMED | ↓ Sell | 20,000 | $94.50 | $1.9M | Direct | Feb 27, 2026 (2d) |
| Feb 12, 2026 | GMED | ↓ Sell | 10,000 | $87.67 | $877K | Direct | Feb 17, 2026 (5d) |
| Nov 25, 2025 | GMED | ↓ Sell | 7,500 | $90.00 | $675K | Direct | Nov 28, 2025 (3d) |
| Dec 2, 2024 | GMED | ↓ Sell | 2,500 | $87.00 | $218K | Direct | Dec 4, 2024 (2d) |
| Nov 6, 2024 | GMED | ↓ Sell | 5,000 | $81.01 | $405K | Direct | Nov 8, 2024 (2d) |
| Oct 16, 2024 | GMED | ↓ Sell | 7,500 | $75.02 | $563K | Direct | Oct 18, 2024 (2d) |
| Mar 1, 2024 | GMED | ↓ Sell | 7,500 | $54.10 | $406K | Direct | Mar 5, 2024 (4d) |
| Dec 1, 2022 | GMED | ↓ Sell | 7,500 | $75.00 | $563K | Direct | Dec 5, 2022 (4d) |
| Apr 8, 2022 | GMED | ↓ Sell | 2,500 | $75.58 | $189K | Direct | Apr 11, 2022 (3d) |
| Dec 28, 2020 | GMED | ↓ Sell | 2,000 | $66.15 | $132K | Direct | Dec 29, 2020 (1d) |
| Aug 6, 2020 | GMED | ↓ Sell | 12,000 | $55.84 | $670K | Direct | Aug 10, 2020 (4d) |
| Jun 11, 2020 | GMED | ↓ Sell | 9,076 | $51.00 | $463K | Direct | Jun 15, 2020 (4d) |
| Dec 17, 2019 | GMED | ↓ Sell | 6,460 | $58.90 | $380K | Direct | Dec 19, 2019 (2d) |
| Nov 7, 2019 | GMED | ↓ Sell | 3,000 | $55.90 | $168K | Direct | Nov 12, 2019 (5d) |
| Nov 1, 2019 | GMED | ↓ Sell | 3,000 | $52.90 | $159K | Direct | Nov 4, 2019 (3d) |
| Aug 2, 2019 | GMED | ↓ Sell | 3,000 | $49.90 | $150K | Direct | Aug 29, 2019 (27d) |
| Mar 28, 2019 | GMED | ↓ Sell | 3,000 | $48.59 | $146K | Direct | Apr 1, 2019 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other GMED insiders
Open-market trades in the last 12 months
About Kelly Huller's insider trades
Kelly Huller is EVP, GC, Corporate Secretary at Globus Medical (GMED). Since Mar 28, 2019, Kelly has reported no open-market purchases and 17 sales worth $8.1M on SEC Form 4. In the last 12 months: 3 sales ($3.4M).
Their filings also include option exercises (13 filings), grants and awards (8 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GMED insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.